The genotoxicity of vitamin c in vitro

Bosnian Journal of Basic Medical Sciences

Volumn 8, Issue 2, 2008, Pages 141-146

  Nefić, Hilada ^a  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

Chromosome abnormalities; Human lymphocytes; Vitamin C (ascorbic acid)

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; COLCHICINE; MUTAGENIC AGENT;

ANAPHASE; ARTICLE; CHROMOSOME; CHROMOSOME ABERRATION; DNA DAMAGE; HUMAN; IN VITRO STUDY; LYMPHOCYTE; METABOLISM; MITOSIS; MITOSIS SPINDLE; TELOPHASE; ULTRASTRUCTURE;

ANAPHASE; ANTIOXIDANTS; ASCORBIC ACID; CHROMOSOME ABERRATIONS; CHROMOSOMES; COLCHICINE; DNA DAMAGE; HUMANS; LYMPHOCYTES; MITOSIS; MITOTIC SPINDLE APPARATUS; MUTAGENS; TELOPHASE;

EID: 55949130092     PISSN: 15128601     EISSN: None     Source Type: Journal    
DOI: 10.17305/bjbms.2008.2969     Document Type: Article

References (25)

1. Shamberger R.J. Genetic toxicology of ascorbic acid. Mutat. Res. 1984; 133:135-159.
2. Anderson D. Antioxidant defenses against reactive oxygen species causing genetic and other damage. Mutat. Res. 1996; 350:103-108.
3. Odin A.P. Vitamins as antimutagens: Advantages and some possible mechanisms of antimutagenic action. Mutat. Res. 1997; 386:39-67.
4. Moorhead P.S., Nowell P.C., Mellman W.J., Batipps D.M., Hun- gerford D.A. Chromosome preparations of leucocytes cultured from human peripheral blood. Exp. Cell Res. i960; 20:613-616.
5. Antunes L.M.G., Takahashi C.S. Protection and Induction of Chromosomal Damage by Vitamin C in Human Lymphocyte Cultures. Teratog., Carcinog., Mutagen. 1999; 19:53-59.
6. Nefic H. Anticlastogenic effect of vitamin C on cisplatin induced chromosome aberrations in human lymphocyte cultures. Mutat. Res. 2001; 49 8:89-9 8.
7. Speit G., Wolf M., Vogel W. The SCE-inducing capacity of vitamin C: investigations in vitro and in vivo. Mutat. Res.1980; 78:273-278.
8. Green M.H.L., Lowe J.E., Waugh A.P.W., Aldridge K.E., Cole J., Arlett C.F. Effect of diet and vitamin C on DNA strand breakage in freshly-isolated human white blood cells. Mutat. Res. 1994; 316:91-102.
9. Anderson D., Yu T.-W., Phillips B.J., Schmezer P. The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA damage in human lymphocytes in the COMET assay. Mutat. Res. 1994; 307:261-271.
10. Galloway S.M., Painter R.B. Vitamin C is positive in the DNA synthesis inhibition and sister-chromatid exchange tests. Mutat. Res. 1979:60:321-327.
11. Anderson D., Basaran N., Blowers S.D., Edwards A.J. The effect of antioxidants on bleomycin treatment in in vitro and in vivo geno- toxicity assays. Mutat. Res. 1995; 329:37-47.
12. Ghaskadbi S., Rajmachikar S., Agate C., Kapadi A.H., Vaidya V.G. Modulation of cyclophosphamide mutagenicity by vitamin C in the in vivo rodent micronucleus assay. Teratog., Carcinog., Mutagen. 1992; 12:11-17.
13. Antunes L.M.G., Takahashi C.S. Effects of high doses of vitamins C and E against doxorubicin-induced chromosomal damage in Wistar rat bone marrow cells. Mutat. Res. 1998; 419:137-143.
14. Antunes L.M.G., Darin J.D.C., Bianchi,M.L.P. Anticlastogenic effect of vitamin C on cisplatin in vivo. Genet. Mol. Biol. 1999; 22:415-418.
15. Gentile J.M., Rahimi S., Zwiesler J., Gentile G.J., Ferguson L.R. Effect of selected antimutagens on the genotoxicity of antitumor agents. Mutat. Res. 1998; 402:289-298.
16. Giri A., Khynriam D., Prasad S.B. Vitamin C medited protection on cisplatin-induced mutagenicity in mice. Mutat. Res. 1998; 421:139-148.
17. Antunes L.M.G., Araújo M.C.P., Darin J.D.C., Bianchi M.L.P. Effects of the antioxidants curcumin and vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cells. Mutat. Res. 2000:465:131-137.
18. Kojima H., Konishi H., Kuroda Y. Effects of L-ascorbic acid on the mutagenicity of ethyl methanesulfonate in cultured mammalian cells. Mutat. Res. 1992; 266:85-91.
19. Krishna G., Nath J., Ong,T. Inhibition of cyclophosphamide and mitomycin C-induced sister chromatid exchanges in mice by vitamin C. Cancer Res. 1986; 46:2670-2674.
20. Kuroda Y. Antimutagenic activity of vitamins in cultured mammalian cells. In: Kuroda Y., Shankel D.M., Waters M.D. (eds), An-timutagenesis and Anticarcinogenesis Mechanisms II. Plenum Press, New York, 1990.
21. Amara-Mokrane Y.A., Lebucher-Michel M.P., Balansard G., Du-m?nil G., Botta B. Protective effects of a-hederin, chlorophillin and ascorbic acid towards the induction of micronuclei by dox-orubicin in cultured human lymphocytes. Mutagenesis. 1996; 11:161-167.
22. Cozzi R., Ricordy R., Aglitti,T., Gatta V., Perticone P., De Salvia R. Ascorbic acid and β-carotene as modulators of oxidative damage. Carcinogenesis. 1997; 18:223-228.
23. Park C.H. Biological nature of the effect of ascorbic acids on the growth of human leukemic cells. Cancer Res. 1985; 45:3969-3973-
24. Osmak M., Kovacek I., Ljubenkov I., Spaventi R., Eckert-Maksic M. Ascorbic acid and 6-deoxy-6-chloro-ascorbic acid: potential anticancer drugs. Neoplasma. 1997; 44:101-107.
25. Block G. Vitamin C status and cancer: epidemiologic evidence of reduced risk. Ann NY Acad Sci. 1992; 669:280-290.